FINWIRES · TerminalLIVE
FINWIRES

$MPLT

28 stories mentioning MPLTUpdated 38d ago

Every FINWIRES story that references MPLT, newest first.

What are analysts saying about MPLT?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on MPLT?

Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $1,024,719, According to a Recent SEC Filing

Vishwas Setia, Chief Financial Officer, on May 04, 2026, sold 36,371 shares in Maplight Therapeutics (MPLT) for $1,024,719. Following the Form 4 filing with the SEC, Setia has control over a total of 356,256 voting common shares of the company, with 356,256 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202125626000008/xslF345X05/form4-05062026_080509.xml

$MPLT
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $1,427,594, According to a Recent SEC Filing

Erin Pennock Foff, Chief Medical Officer, on May 04, 2026, sold 50,280 shares in Maplight Therapeutics (MPLT) for $1,427,594. Following the Form 4 filing with the SEC, Foff has control over a total of 350,497 voting common shares of the company, with 350,497 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202123326000008/xslF345X05/form4-05062026_080507.xml

$MPLT
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $1,468,251, According to a Recent SEC Filing

James Woodruff Lillie, Chief Scientific Officer, on May 04, 2026, sold 51,707 shares in Maplight Therapeutics (MPLT) for $1,468,251. Following the Form 4 filing with the SEC, Lillie has control over a total of 243,450 voting common shares of the company, with 243,450 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000172874626000008/xslF345X05/form4-05062026_080505.xml

$MPLT
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $388,177, According to a Recent SEC Filing

Kristopher Hanson, General Counsel, on May 04, 2026, sold 13,917 shares in Maplight Therapeutics (MPLT) for $388,177. Following the Form 4 filing with the SEC, Hanson has control over a total of 176,248 voting common shares of the company, with 176,248 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000178997026000008/xslF345X05/form4-05062026_080503.xml

$MPLT
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $1,412,236, According to a Recent SEC Filing

Christopher A. Kroeger, Director, Chief Executive Officer, on May 04, 2026, sold 49,744 shares in Maplight Therapeutics (MPLT) for $1,412,236. Following the Form 4 filing with the SEC, Kroeger has control over a total of 1,682,010 voting common shares of the company, with 1,580,820 shares held directly and 101,190 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000165891826000008/xslF345X05/form4-05062026_080501.xml

$MPLT
Research

HC Wainwright Initiates Coverage on MapLight Therapeutics With Buy Rating, $45 Price Target

MapLight Therapeutics, Inc. (MPLT) has an average rating of Buy and mean price target of $34.43, according to analysts polled by FactSet.

$MPLT
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $1,347,066, According to a Recent SEC Filing

Anatol Kreitzer, Chief Discovery Officer, on April 27, 2026, sold 45,422 shares in Maplight Therapeutics (MPLT) for $1,347,066. Following the Form 4 filing with the SEC, Kreitzer has control over a total of 211,190 voting common shares of the company, with 211,190 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202123826000008/xslF345X05/form4-04292026_040429.xml

$MPLT
Insider Trading

Maplight Therapeutics Insider Sold Shares Worth $2,087,687, According to a Recent SEC Filing

Jonathan Gillis, Chief Administrative and Accounting Officer and Principal Accounting Officer, on April 27, 2026, sold 69,835 shares in Maplight Therapeutics (MPLT) for $2,087,687. Following the Form 4 filing with the SEC, Gillis has control over a total of 181,219 voting common shares of the company, with 181,219 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000170995426000008/xslF345X05/form4-04292026_040431.xml

$MPLT

Showing 21-28 of 28

Track with the FINWIRES app suite

FolioX
FolioX
Track MPLT in your portfolio
WheelAI
WheelAI
Analyze MPLT options with the wheel strategy
StockInsider
StockInsider
See market sentiment on MPLT